FOOT AMPUTATION side effect
What is FOOT AMPUTATION ?Drugs associated with FOOT AMPUTATION
ALEVE CEREZYME FABRAZYME HUMALOG HUMULIN LANTUS LETROZOLE MOXIFLOXACIN NATALIZUMAB NOREPINEPHRINE RENAGEL RITUXIMAB SUTENT TEVETEN THYMOGLOBULINFOOT AMPUTATION : Humulin Side Effects Report #5620351-2
Consumer or non-health professional from TURKEY reported HUMULIN problem on Jan 28, 2008. Female patient, weighting 176.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with HUMULIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, toe amputation, . HUMULIN dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.
FOOT AMPUTATION : Renagel Side Effects Report #5510677-5
RENAGEL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 29, 2007. Male patient was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: foot amputation, toe amputation, . RENAGEL dosage: unknown. Patient recovered.
FOOT AMPUTATION : Moxifloxacin Side Effects Report #5486700-3
Physician from SOUTH AFRICA reported MOXIFLOXACIN problem on Oct 12, 2007. Male patient, 72 years of age, weighting 145.5 lb, was diagnosed with skin infection, medical diet, anaesthesia, hypotonia and was treated with MOXIFLOXACIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, leg amputation, wound debridement, . MOXIFLOXACIN dosage: unknown. During the same period patient was treated with VITAMIN CAP, ASCORBIC ACID, THIAMINE, DIPRIVAN, PROSTIGMIN BROMIDE, ROBINUL, TACRIUM. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Natalizumab Side Effects Report #5450887-9
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Sept 04, 2007. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: foot amputation, limb injury, road traffic accident, . NATALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Renagel Side Effects Report #5410275-8
Health Professional from UNITED STATES reported RENAGEL problem on July 25, 2007. Male patient, 48 years of age, weighting 163.1 lb, was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: foot amputation, gangrene, hypocalcaemia, . RENAGEL dosage: unknown. During the same period patient was treated with EPOGEN, VENOFER, TOPAMAX, WARFARIN, ASCORBIC ACID, CALCIUM WITH VITAMIN D. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Rituximab Side Effects Report #5418976-2
RITUXIMAB problem was reported by a Physician from GERMANY on Aug 14, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: foot amputation, localised infection, multi-organ failure, staphylococcal sepsis, . RITUXIMAB dosage: unknown. During the same period patient was treated with REMICADE, METHOTREXATE, LEFLUNOMIDE, METYSOLON, VOLTAREN, MOBIC, RAMIPRIL, CALCIUM D. Patient was hospitalized. Patient died on 04/21/2007.
FOOT AMPUTATION : Teveten Side Effects Report #5391725-2
Health Professional from UNITED STATES reported TEVETEN problem on July 03, 2007. Male patient, 77 years of age, was diagnosed with hypertension and was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: foot amputation, . TEVETEN dosage: 600 MG QD PO. During the same period patient was treated with ATENOLOL, GLICLAZIDE, METFORMIN. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Thymoglobulin Side Effects Report #5423728-3
THYMOGLOBULIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2004. Male patient, 53 years of age, weighting 180.3 lb, was diagnosed with renal transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, leg amputation, vascular insufficiency, . THYMOGLOBULIN dosage: 125 MG QD. During the same period patient was treated with ASPIRIN, CELLCEPT, INSULIN, ACYCLOVIR, ALLOPURINOL, CELEXA, PLAVIX, SENOKOT. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Teveten Side Effects Report #5391725-2
Health Professional from UNITED STATES reported TEVETEN problem on July 03, 2007. Male patient, 77 years of age, was diagnosed with hypertension and was treated with TEVETEN. After drug was administered, patient experienced the following problems/side effects: foot amputation, . TEVETEN dosage: 600 MG QD PO. During the same period patient was treated with ATENOLOL, GLICLAZIDE, METFORMIN. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Thymoglobulin Side Effects Report #5423728-3
THYMOGLOBULIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2004. Male patient, 53 years of age, weighting 180.3 lb, was diagnosed with renal transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: foot amputation, leg amputation, vascular insufficiency, . THYMOGLOBULIN dosage: 125 MG QD. During the same period patient was treated with ASPIRIN, CELLCEPT, INSULIN, ACYCLOVIR, ALLOPURINOL, CELEXA, PLAVIX, SENOKOT. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Sutent Side Effects Report #5596494-9
Physician from GERMANY reported SUTENT problem on Jan 09, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: cutis laxa, foot amputation, . SUTENT dosage: DAILY DOSE:50MG. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Renagel Side Effects Report #5556180-8
RENAGEL problem was reported by a Physician from UNITED STATES on Nov 26, 2007. Male patient was diagnosed with hyperphosphataemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, foot amputation, osteomyelitis, peripheral vascular disorder, toe amputation, . RENAGEL dosage: unknown. Patient recovered.
FOOT AMPUTATION : Sutent Side Effects Report #5572241-1
Physician from GERMANY reported SUTENT problem on Dec 11, 2007. Male patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: cutis laxa, foot amputation, . SUTENT dosage: unknown. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Humalog Side Effects Report #5487590-5
HUMALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 2007. Female patient was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: foot amputation, vomiting, . HUMALOG dosage: unknown. Patient died.
FOOT AMPUTATION : Norepinephrine Side Effects Report #5489552-0
Pharmacist from UNITED STATES reported NOREPINEPHRINE BITARTRATE problem on Oct 16, 2007. Female patient, 54 years of age, weighting 191.6 lb, was diagnosed with hypotension, septic shock and was treated with NOREPINEPHRINE BITARTRATE. After drug was administered, patient experienced the following problems/side effects: dry gangrene, foot amputation, peripheral ischaemia, . NOREPINEPHRINE BITARTRATE dosage: unknown. During the same period patient was treated with NOREPINEPHRINE BITARTRATE, VASOPRESSIN, AZITHROMYCIN, CEFTRIAXONE, CEFTAZIDIME, CLINDAMYCIN, TOBRAMYCIN. Patient recovered.
FOOT AMPUTATION : Fabrazyme Side Effects Report #5467038-7
FABRAZYME problem was reported by a Physician from UNITED STATES on Sept 24, 2007. Male patient, 34 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, foot amputation, . FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with TORSEMIDE, PROGRAF, PREDNISONE, COLACE, CALCITRIOL, ZOLOFT. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Letrozole Side Effects Report #5535167-5
Physician from DENMARK reported LETROZOLE VS TAMOXIFEN problem on Nov 29, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with breast cancer and was treated with LETROZOLE VS TAMOXIFEN. After drug was administered, patient experienced the following problems/side effects: arterial stenosis limb, arteriosclerosis, foot amputation, intermittent claudication, peripheral arterial occlusive disease, . LETROZOLE VS TAMOXIFEN dosage: 2.5 MG, QD. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Letrozole Side Effects Report #5513765-2
LETROZOLE problem was reported by a Physician from DENMARK on Nov 02, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with breast cancer and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: arterial stenosis limb, arteriosclerosis, foot amputation, intermittent claudication, peripheral arterial occlusive disease, . LETROZOLE dosage: 2.5 MG, QD. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Letrozole Side Effects Report #5523072-X
Physician from DENMARK reported LETROZOLE VS TAMOXIFEN problem on Nov 13, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with breast cancer and was treated with LETROZOLE VS TAMOXIFEN. After drug was administered, patient experienced the following problems/side effects: arterial stenosis limb, arteriosclerosis, foot amputation, intermittent claudication, peripheral arterial occlusive disease, . LETROZOLE VS TAMOXIFEN dosage: 2.5 MG, QD. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Lantus Side Effects Report #5450039-2
LANTUS problem was reported by a Health Professional from INDIA on Sept 07, 2007. Female patient, 56 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: diabetic foot, fall, foot amputation, gangrene, hypoglycaemia, impaired healing, limb injury, sepsis, toe amputation, . LANTUS dosage: unknown. During the same period patient was treated with LISPRO, METFORMIN, HUMALOG. Patient was hospitalized. Patient recovered.
FOOT AMPUTATION : Aleve Side Effects Report #5430471-3
Consumer or non-health professional from UNITED STATES reported ALEVE problem on Aug 23, 2007. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with nerve compression and was treated with ALEVE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, foot amputation, gastric perforation, gastric ulcer, gastric ulcer surgery, skin discolouration, toe amputation, unevaluable event, . ALEVE dosage: UNIT DOSE: 220 MG. Patient was hospitalized and became disabled. Patient recovered.
FOOT AMPUTATION : Cerezyme Side Effects Report #5441850-2
CEREZYME problem was reported by a Physician from UNITED STATES on Aug 15, 2007. Female patient was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, dialysis, foot amputation, renal failure chronic, . CEREZYME dosage: unknown. Patient was hospitalized. Patient recovered.